Page last updated: 2024-09-03

1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and angiotensin ii

1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone has been researched along with angiotensin ii in 1 studies

Compound Research Comparison

Studies
(1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone)
Trials
(1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone)
Recent Studies (post-2010)
(1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
7,66601,65838,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomy1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busk, PK; Hansen, AH; Haunsø, S; Hinrichsen, R1

Other Studies

1 other study(ies) available for 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and angiotensin ii

ArticleYear
Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy.
    Cell proliferation, 2008, Volume: 41, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Proliferation; Cells, Cultured; Cyclin D; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclins; DNA; DNA Replication; E2F Transcription Factors; Hexanones; Myocytes, Cardiac; Phosphorylation; Protein Biosynthesis; Purines; Rats; Rats, Wistar; Retinoblastoma Protein; Roscovitine; Up-Regulation

2008